Combination strategy to circumvent the acquired resistance to VEGF receptor tyrosine kinase inhibitor in M24met melanoma in mice

被引：0
|
作者：
Zhang, Lianglin [1 ]
Lira, Maruja E. [1 ]
Ching, Keith A. [1 ]
Chen, Enhong [1 ]
Lu, Tina [1 ]
Christensen, James G. [1 ]
Hu-Lowe, Dana D. [1 ]
机构：
[1] Pfizer Inc, San Diego, CA USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-3270
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3270
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The dual EGF/VEGF receptor tyrosine kinase inhibitor AEE788 inhibits growth of human hepatocellular carcinoma xenografts in nude mice
    Okamoto, Kinya
    Neureiter, Daniel
    Alinger, Beate
    Meissnitzer, Matthias
    Sass, Gabriele
    Schmitz, Volker
    Di Fazio, Pietro
    Wissniowski, Till
    Gahr, Susanne
    Hohenstein, Bernd
    Kaufmann, Bernhard
    Schloesser, Axel
    Haus, Ulrike
    Hahn, Eckhart G.
    Herold, Christoph
    Ocker, Matthias
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 33 (04) : 733 - 742
  • [32] Continuation of epidermal growth factor receptor tyrosine kinase inhibitor treatment prolongs disease control in non-small-cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitors
    Chen, Qi
    Quan, Qi
    Ding, Lingyu
    Hong, Xiangchan
    Zhou, Ningning
    Liang, Ying
    Wu, Haiying
    ONCOTARGET, 2015, 6 (28) : 24904 - 24911
  • [33] Clinical strategies for acquired epidermal growth factor receptor tyrosine kinase inhibitor resistance in non-small-cell lung cancer patients
    Dong, Lijun
    Lei, Dan
    Zhang, Haijun
    ONCOTARGET, 2017, 8 (38) : 64600 - 64606
  • [34] Rebiopsy of Non-Small Cell Lung Cancer Patients With Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor
    Hata, Akito
    Katakami, Nobuyuki
    Yoshioka, Hiroshige
    Takeshita, Jumpei
    Tanaka, Kosuke
    Nanjo, Shigeki
    Fujita, Shiro
    Kaji, Reiko
    Imai, Yukihiro
    Monden, Kazuya
    Matsumoto, Takeshi
    Nagata, Kazuma
    Otsuka, Kyoko
    Tachikawa, Ryo
    Tomii, Keisuke
    Kunimasa, Kei
    Iwasaku, Masahiro
    Nishiyama, Akihiro
    Ishida, Tadashi
    Nishimura, Yoshihiro
    CANCER, 2013, 119 (24) : 4325 - 4332
  • [35] β1 INTEGRIN MEDIATED ACQUIRED RESISTANCE TO EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR IN NON-SMALL LUNG CANCER CELLS
    Deng, Q-F
    Xu, J-F
    Zhou, C-C
    Su, B.
    Zhao, Y-M
    RESPIROLOGY, 2011, 16 : 185 - 185
  • [36] β1 integrin mediated acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitor in non-small lung cancer cells
    Deng, Q.
    Zhou, S.
    Su, B.
    Zhao, Y.
    Zhou, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
    Huang, Yen-Hsiang
    Hsu, Kuo-Hsuan
    Tseng, Jeng-Sen
    Chen, Kun-Chieh
    Hsu, Chia-Hung
    Su, Kang-Yi
    Chen, Jeremy J. W.
    Chen, Huei-Wen
    Yu, Sung-Liang
    Yang, Tsung-Ying
    Chang, Gee-Chen
    CANCER RESEARCH AND TREATMENT, 2018, 50 (04): : 1294 - 1303
  • [38] The dual EGF-/VEGF-receptor tyrosine kinase inhibitor AEE-788 inhibits growth of human hepatocellular carcinoma xenografts in mice
    Okamoto, K.
    Neureiter, D.
    Alinger, B.
    Sass, G.
    Schmitz, V.
    Di Fazio, P.
    Wissniowski, T.
    Hahn, E. G.
    Ocker, M.
    ONKOLOGIE, 2008, 31 : 78 - 78
  • [39] The dual EGF-/VEGF-receptor tyrosine kinase inhibitor AEE-788 inhibits growth of human hepatocellular carcinoma xenografts in mice
    Ocker, M.
    Okamoto, K.
    Neureiter, D.
    Kaufmann, B.
    Haus, U.
    Herold, C.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S143 - S144
  • [40] The dual EGF-/VEGF-receptor tyrosine kinase inhibitor AEE-788 inhibits growth of human hepatocellular carcinoma xenografts in mice
    Ocker, Matthias
    Kaufmann, Bernhard
    Haus, Ulrike
    Herold, Christoph
    HEPATOLOGY, 2006, 44 (04) : 696A - 697A
12345